Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net earnings/(loss)	$ 925	$ 818
Adjustments to reconcile net earnings to net cash provided by/(used in) operating activities:
Depreciation and amortization	467	374
Impairments and (gain)/loss on disposal of assets, net	(12)	2
Impairments and loss on sale of other investments	(5)	(2)
Share-based compensation	180	60
Provision for bad debts	27	28
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(198)	(253)
Increase in inventories	(3,279)	(1,967)
Increase/(decrease) in accounts payable	4,176	(470)
Repurchases of liability-classified units	(22)	0
Other accrued liabilities and operating items, net	(610)	(637)
Net cash provided by/(used in) operating activities	1,659	(2,043)
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	1,925	1,076
Additions to property and equipment	(239)	(189)
Proceeds from disposal of property and equipment	31	0
Proceeds from short-term investment in time deposit	0	200
Net cash used in investing activities	(2,122)	(1,064)
Cash flows from financing activities:
Proceeds from long-term obligations, net of issuance costs	989	2,869
Reduction of long-term obligations	(524)	(423)
Payments to Noncontrolling Interests	4	4
Net tax withholding from share-based compensation	(81)	(15)
Dividends on common shares	(251)	(250)
Purchase of treasury shares, net	(758)	(390)
Net cash provided by/(used in) financing activities	(629)	1,787
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	(5)	(3)
Net decrease in cash and equivalents	(1,097)	(1,323)
Cash and equivalents at beginning of period	3,874	5,133
Cash and equivalents at end of period	2,777	3,810
Payments to Noncontrolling Interests	(4)	(4)
Increase (decrease) in other investing items, net	$ 11	$ 1